Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Issue 3 (23rd February 2021)
- Record Type:
- Journal Article
- Title:
- Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Issue 3 (23rd February 2021)
- Main Title:
- Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
- Authors:
- Megías-Vericat, Juan Eduardo
Martínez-Cuadrón, David
Herrero, María José
Rodríguez-Veiga, Rebeca
Solana-Altabella, Antonio
Boluda, Blanca
Ballesta-López, Octavio
Cano, Isabel
Acuña-Cruz, Evelyn
Cervera, José
Poveda, José Luis
Sanz, MiguelÁngel
Aliño, Salvador F.
Montesinos, Pau - Abstract:
- Abstract: Anthracycline uptake could be affected by influx and efflux transporters in acute myeloid leukemia (AML). Combinations of single-nucleotide polymorphisms (SNPs) of wild-type genotype of influx transporters ( SLC22A16, SLCO1B1 ) and homozygous variant genotypes of ABC polymorphisms ( ABCB1, ABCC1, ABCC2, ABCG2 ) were evaluated in 225 adult de novo AML patients. No differences in complete remission were reported, but higher induction death was observed with combinations of SLCO1B1 rs4149056 and ABCB1 (triple variant haplotype, rs1128503), previously associated with ABCB1 and SLCO1B1 SNPs. Several combinations of SLCO1B1 and SLC22A16 with ABCB1 SNPs were associated with higher toxicities, including nephrotoxicity and hepatotoxicity, neutropenia, previously related to ABCB1, and a novel correlation with mucositis. Combination of SLC22A16 rs714368 and ABCG2 rs2231142 was related to cardiac toxicity, reproducing previous correlations with ABCG2 . This study shows the impact of transporter polymorphisms in AML chemotherapy safety. Further prospective studies with larger populations are needed to validate these associations.
- Is Part Of:
- Leukemia & lymphoma. Volume 62:Issue 3(2021)
- Journal:
- Leukemia & lymphoma
- Issue:
- Volume 62:Issue 3(2021)
- Issue Display:
- Volume 62, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 62
- Issue:
- 3
- Issue Sort Value:
- 2021-0062-0003-0000
- Page Start:
- 659
- Page End:
- 668
- Publication Date:
- 2021-02-23
- Subjects:
- SLCO1B1 -- ABCB1 -- polymorphism -- anthracyclines -- idarubicin -- SNP-SNP combination
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419 - Journal URLs:
- http://informahealthcare.com ↗
- DOI:
- 10.1080/10428194.2020.1839650 ↗
- Languages:
- English
- ISSNs:
- 1042-8194
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22668.xml